132 related articles for article (PubMed ID: 32114428)
1. Inhibition of p-mTOR represses transcription of PS1 and Notch 1-signaling.
Das HK; Hontiveros SS
Front Biosci (Landmark Ed); 2020 Mar; 25(6):1172-1183. PubMed ID: 32114428
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of p-mTOR represses PS1 transcription by reducing p-JNK.
Das HK; Hontiveros SS
Front Biosci (Landmark Ed); 2020 Mar; 25(7):1297-1304. PubMed ID: 32114433
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal injection of JNK-specific inhibitor SP600125 inhibits the expression of presenilin-1 and Notch signaling in mouse brain without induction of apoptosis.
Rahman M; Zhang Z; Mody AA; Su DM; Das HK
Brain Res; 2012 Apr; 1448():117-28. PubMed ID: 22353755
[TBL] [Abstract][Full Text] [Related]
4. Ameliorating Ribosylation-Induced Amyloid-β Pathology by Berberine via Inhibiting mTOR/p70S6K Signaling.
Wang YY; Yan Q; Huang ZT; Zou Q; Li J; Yuan MH; Wu LQ; Cai ZY
J Alzheimers Dis; 2021; 79(2):833-844. PubMed ID: 33361598
[TBL] [Abstract][Full Text] [Related]
5. [Effect of moxibustion on autophagy in mice with Alzheimer's disease based on mTOR/p70S6K signaling pathway].
Wu YY; Song XG; Zhu CF; Cai SC; Ge X; Wang L; Jia YM
Zhongguo Zhen Jiu; 2022 Sep; 42(9):1011-6. PubMed ID: 36075597
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibitory effect of rapamycin in Hodgkin-lymphoma cell lines characterized by constitutive NOTCH1 activation.
Nagy N; Hajdu M; Márk Á; Király PA; Tóth M; Dankó T; Csóka M; Sebestyén A
Tumour Biol; 2016 Oct; 37(10):13695-13704. PubMed ID: 27473087
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin promotes presenilin-1 expression and Notch1 activity and increases neural progenitor cell proliferation after stroke.
Chen J; Zacharek A; Li A; Cui X; Roberts C; Lu M; Chopp M
Stroke; 2008 Jan; 39(1):220-6. PubMed ID: 18063826
[TBL] [Abstract][Full Text] [Related]
8. Notch1 competes with the amyloid precursor protein for gamma-secretase and down-regulates presenilin-1 gene expression.
Lleó A; Berezovska O; Ramdya P; Fukumoto H; Raju S; Shah T; Hyman BT
J Biol Chem; 2003 Nov; 278(48):47370-5. PubMed ID: 12960155
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice.
Ding Y; Liu H; Cen M; Tao Y; Lai C; Tang Z
Neurochem Res; 2021 Feb; 46(2):265-275. PubMed ID: 33140268
[TBL] [Abstract][Full Text] [Related]
10. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.
Caccamo A; Majumder S; Richardson A; Strong R; Oddo S
J Biol Chem; 2010 Apr; 285(17):13107-20. PubMed ID: 20178983
[TBL] [Abstract][Full Text] [Related]
11. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
[TBL] [Abstract][Full Text] [Related]
12. The immunosuppressant tributyltin oxide blocks the mTOR pathway, like rapamycin, albeit by a different mechanism.
Osman AM; van Loveren H
J Appl Toxicol; 2014 Dec; 34(12):1361-7. PubMed ID: 24375594
[TBL] [Abstract][Full Text] [Related]
13. Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1.
Zang C; Eucker J; Liu H; Müller A; Possinger K; Scholz CW
Cancer Lett; 2013 Oct; 339(2):288-97. PubMed ID: 23200668
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice.
Wang C; Zhang X; Teng Z; Zhang T; Li Y
Eur J Pharmacol; 2014 Oct; 740():312-20. PubMed ID: 25041840
[TBL] [Abstract][Full Text] [Related]
15. Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation.
Hibdon ES; Razumilava N; Keeley TM; Wong G; Solanki S; Shah YM; Samuelson LC
Neoplasia; 2019 Jul; 21(7):702-712. PubMed ID: 31129492
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease.
Spilman P; Podlutskaya N; Hart MJ; Debnath J; Gorostiza O; Bredesen D; Richardson A; Strong R; Galvan V
PLoS One; 2010 Apr; 5(4):e9979. PubMed ID: 20376313
[TBL] [Abstract][Full Text] [Related]
17. Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling.
Halicka HD; Zhao H; Li J; Lee YS; Hsieh TC; Wu JM; Darzynkiewicz Z
Aging (Albany NY); 2012 Dec; 4(12):952-65. PubMed ID: 23363784
[TBL] [Abstract][Full Text] [Related]
18. mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cells.
Liu J; Stevens PD; Gao T
J Biol Chem; 2011 Feb; 286(8):6510-20. PubMed ID: 21177869
[TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity.
Liu L; Luo Y; Chen L; Shen T; Xu B; Chen W; Zhou H; Han X; Huang S
J Biol Chem; 2010 Dec; 285(49):38362-73. PubMed ID: 20937815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
